National Probe May Help Curb Rise in Prices of Blood Products, Expert Says

(Beijing) – The price of blood products are likely to decline as the government carries out a national inspection on drug pricing, an executive of a manufacturer in this industry said.

The National Development and Reform Commission (NDRC), the country's top economic planner, said it will carry out spot checks on at least 10 percent of drug makers who produce medicines using blood components in July and August, in a directive published on its website on May 27.